🇺🇸 FDA
Patent

US 10292940

Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof

granted A61KA61K31/704A61K31/728

Quick answer

US patent 10292940 (Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof) held by BrightGene Bio-Medical Technology Co., Ltd. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BrightGene Bio-Medical Technology Co., Ltd.
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/704, A61K31/728, A61K31/795, A61K47/183